Turning up the heat: treating 'cold' tumors with combinatorial cancer immunotherapies.

加大力度：用组合癌症免疫疗法治疗“冷”肿瘤。

• 批准号: 416561
• 负责人: Smazynski Julian
• 金额: $ 7.65万
• 依托单位: University of Victoria (British Columbia)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-11-01 至 2022-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=416561&lang=en
• 关键词: Cancer Immunotherapy; Cancer/Oncology; High Dimensional Flow Cytometry; Immune Checkpoint Blockade; Immunology; Oncolytic Virus Therapy; Single Cell Sequencing; Tumor Microenvironment; Tumor-Infiltrating Lymphocytes; Virology

Cancer immunotherapy is a rapidly growing field of research which has led to several unprecedented advances in cancer treatment. Key to the success of immunotherapy are T cells, a type of white blood cell that can recognize and kill cancer cells. However,

癌症免疫治疗是一个快速发展的研究领域，在癌症治疗方面取得了一些前所未有的进展。免疫疗法成功的关键是T细胞，这是一种能够识别并杀死癌细胞的白细胞。然而,